Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Dyspepsia × Rabeprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Gastrointestinal Hemorrhage 1 Dyspepsia 1 Adenocarcinoma 1

Interventions

Bismuth 5 Amoxicillin 4 Tetracycline 3 Esomeprazole 3 Clarithromycin 3 Furazolidone 2 Rabeprazole 1 Minocycline 1 Berberine 1 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04697186 2023-01-31

Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy

Xijing Hospital of Digestive Diseases

Phase 4 Completed

Gastrointestinal

Dyspepsia, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡